BRAF mutations are not an alternative explanation for the molecular etiology of ras-mutation negative cold thyroid nodules

Thyroid

Volumn 14, Issue 5, 2004, Pages 359-361

  Krohn, Knut ^a,b   Paschke, Ralf ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MITOGEN ACTIVATED PROTEIN KINASE; PLASMID DNA; RAF PROTEIN; RAS PROTEIN;

ARTICLE; CELL PROLIFERATION; DENATURING GRADIENT GEL ELECTROPHORESIS; EXON; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THYROID DISEASE; THYROID NODULE; TUMOR CELL;

EXONS; GENES, RAS; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS; THYROID NODULE;

EID: 2942585069     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072504774193186     Document Type: Article

References (14)

1. Wynford-Thomas D 1997 Origin and progression of thyroid epithelial tumours: Cellular and molecular mechanisms. Horm Res 47:145-157.
2. Esapa CT, Johnson SJ, Kendall-Taylor P, Lennard TW, Harris PE 1999 Prevalence of Ras mutations in thyroid neoplasia. Clin Endocrinol (Oxf) 50:529-535.
3. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA 2002 Mutations of the BRAF gene in human cancer. Nature 417:949-954.
4. Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, Stephens P, Edkins S, Tsui WW, Chan AS, Futreal PA, Stratton MR, Wooster R, Leung SY 2002 Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res 62:6451-6455.
5. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454-1457.
6. Krohn K, Reske A, Ackermann F, Paschke R 2001 Ras mutations are rare in solitary cold and toxic thyroid nodules. Clin Endocrinol 55:241-248.
7. Hedinger C 1988 Histological Typing of Thyroid Tumors. Springer Verlag, Berlin Heidelberg New York.
8. Trülzsch B, Krohn K, Wonerow P, Paschke R 1999 DGGE is more sensitive for the detection of somatic point mutations than direct sequencing. Biotechniques 27:266-268.
9. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE 2003 BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-5404.
10. Gire V, Wynford-Thomas D 2000 RAS oncogene activation induces proliferation in normal human thyroid epithelial cells without loss of differentiation. Oncogene 19:737-744.
11. Santelli G, de F, V, Portella G, Chiappetta G, D'Alessio A, Califano D, Rosati R, Mineo A, Monaco C, Manzo G 1993 Production of transgenic mice expressing the Ki-ras oncogene under the control of a thyroglobulin promoter. Cancer Res 53:5523-5527.
12. Chiappetta G, Fabien N, Picone A, Califano D, Monaco C, de F, V, Vecchio G, Santelli G 1996 Transgenic mice carrying the human KRAS oncogene under the control of a thyroglobulin promoter: KRAS expression in thyroids analyzed by in situ hybridization. Oncol Res 8:85-93.
13. Rochefort P, Caillou B, Michiels FM, Ledent C, Talbot M, Schlumberger M, Lavelle F, Monier R, Feunteun J 1996 Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter. Oncogene 12:111-118.
14. Vanvooren V, Allgeier A, Nguyen M, Massart C, Parma J, Dumont JE, Van Sande J 2001 Mutation analysis of the Epac-Rap1 signaling pathway in cold thyroid follicular adenomas. Eur J Endocrinol 144:605-610.